Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma

Haematologica. 2019 Nov;104(11):e523-e526. doi: 10.3324/haematol.2018.213355. Epub 2019 Apr 19.

Authors

Maaike V J Braham¹, Jacqueline Alblas¹, Wouter J A Dhert^{1

2}, F Cumhur Öner¹, Monique C Minnema³

Affiliations

¹ Department of Orthopaedics, University Medical Center Utrecht.
² Faculty of Veterinary Medicine, Utrecht University.
³ Department of Hematology, University Medical Center Utrecht Cancer Center, Utrecht, the Netherlands m.c.minnema@umcutrecht.nl.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / pathology*
Combined Modality Therapy / adverse effects
Combined Modality Therapy / methods
Humans
Molecular Targeted Therapy
Multiple Myeloma / mortality
Multiple Myeloma / pathology*
Multiple Myeloma / therapy*
Prognosis
Treatment Outcome